NR3C1 and post-traumatic stress disorder: SPS induces a series of behavioral, hormonal, and immune alterations that align with the core pathophysiological features of PTSD, including hypothalamic–pituitary–adrenal (HPA) axis dysregulation, glucocorticoid receptor desensitization, and heightened pro-inflammatory signaling [7,8].